Pfizer prepares a modified vaccine against “Omicron” within 100 days
Pfizer and Biontech, the two manufacturers of the emerging coronavirus vaccine, announced that they will be able to export modified vaccines against the new mutated coronavirus within 100 days.
The two companies said that they were collecting information about the “Omicron” mutant to discuss the possibility of modifying their vaccines, according to Al Arabiya.
And Pfizer Inc. said that it had signed a $5.29 billion agreement with the US government to provide 10 million doses of its experimental drug against strains of the Covid-19 virus, at a time when the United States was rushing to secure promising oral treatments for this disease.
The deal is double the size of the US government's contract with Merck & Co, although the price for a single dose of Pfizer's treatment is around $530 compared to about $700 for its counterpart.
Pfizer also applied for emergency authorization for the drug, Paxlovid, after reporting data showing it was 89% effective in preventing hospitalization or death in people at risk.
